🇺🇸 Dihydroartemisinin-Piperaquine drug combination in United States

Dihydroartemisinin-Piperaquine drug combination (Dihydroartemisinin-Piperaquine drug combination) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

Dihydroartemisinin-Piperaquine drug combination in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Dihydroartemisinin-Piperaquine drug combination approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Dihydroartemisinin-Piperaquine drug combination in United States?

University of Yaounde 1 is the originator. The local marketing authorisation holder may differ — check the official source linked above.